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To the Editor,
The role of paediatric patients in transmitting the 
disease to others is unknown, especially given the 
unknown number of asymptomatic cases. Most chil-
dren infected with COVID-19 are asymptomatic or 
have mild symptoms such as coughing, fever or chills, 
breathlessness or respiratory problems, muscle or body 
pain, sore throat, loss of taste or smell, diarrhoea, head-
ache, fatigue, nausea or vomiting, nasal congestion or 
rhinitis. Of the many of these symptoms, if individual 
symptoms occur, they may go unnoticed by the parent. 
Children now account for 10.6% of all infected children, 
of whom 1.8% required hospitalization and did not have 
a severe covid-19 infection, their mortality rate is low and 
remains 0.06% of all deaths and 0.02% of the deaths 
of infected children, as shown by data collected from 
the AAP in the United States [1]. Recently, there have 
also been reports about the duration of the infection in 
children infected with covid-19, who may be infected 
for up to 6 weeks, which could suggest an easy pos-
sibility of infecting others while in contact with them 
[2]. There were also reports of persistent amounts of 
virus nucleic acid in the nasopharynx in individual age 
groups, of which small children under 5 years of age 
have equivalent or higher levels of viral nucleic acid in 
the upper respiratory tract, compared to older children 
and adults. Although this study was limited to the de-
tection of viral nucleic acid and not the infectious virus, 
studies conducted on children with covid-19 infection 
showed a correlation between higher levels of nucleic 
acids and the ability to grow an infectious virus [3]. 
The study also showed that SARS-CoV-2 clearance in 
the airways occurred within two weeks after the fever 
disappeared, while viral RNAs remained detectable in 
the stool of paediatric patients for more than 4 weeks, 
which could suggest the possibility of infection through 
contact with children who were theoretically cured [4]. 
The asymptomatic or very mild COVID-19 transmission 
by paediatric patients, the long duration of the infection, 
as well as the amount of infectious material, suggests 
that children can spread the virus very easily in society. 
In summary, in many countries, small children are 
not required to wear personal protective equipment 
such as masks, which may expose people around them 
to infection. Infections in paediatric patients should be 
further explored, and preventive measures are taken to 
reduce the infections involving them.
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